C. difficile Infection and Recurrence: Targeting the Drivers of Pathogenesis
| Overview / Abstract: |
In this CME eNewsletter, Dr. Paul Feuerstadt will discuss the body’s defenses against C. difficile infection, including the immune response and changes in the gut microbiome. He will also discuss the effect of available therapies on these processes during the treatment of initial and recurrent episodes of C. difficile. This is the final activity in a series of three educational activities on CDI released in 2018. |
|
Expiration |
Nov 27, 2019 |
|
Discipline(s) |
Physician CME |
|
Format |
Online, Webinar / Webcast / Video |
|
Credits / Hours |
.75 AMA PRA Category 1 Credit(s)™ |
|
Presenters / Authors / Faculty |
Paul Feuerstadt, MD |
|
Sponsors / Supporters / Grant Providers |
Supported by an educational grant from Merck & Co., Inc. |
|
Keywords / Search Terms |
ACHL CME, CE, Continuing Medical Education, CME/CE, Online Learning, Interview, Case Study, CDI, CDI Interview, Clostridium difficile, C. diff, Paul Feuerstadt, Feuerstadt, recurrent CDI, Merck, online CME, gastroenterology, infectious diseases, prevent CDI, patient, IDSA, SHEA, guidelines, newsletter, gut microbiome, vancomycin, fidaxomicin, bezlotoxumab, probiotics, FMT Free CE CME |
|